Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Aleeto

According to the groups, patients would be treated with Aleeto via intravenous injection, and the specific dosage of Aleeto will depend on the grouping.

DRUG

Placebo

Placebo with the same dosage form, odor and color as Aleeto was administered in the same way and course of treatment.

Trial Locations (1)

Unknown

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER